Search research articles
Contact Us
Filters
Showing results (181-190 of 193) with videos related to
Page
of 20
Sort By:
Genome Medicine
|
August 15, 2024
Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD
Jonathan E Knikman, Qinglian Zhai, Carin A T C Lunenburg, et al.
Endoscopy
|
February 7, 2024
Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers
Lisa van der Schee, Krijn J C Haasnoot, Sjoerd G Elias, et al.
JNCI Cancer Spectrum
|
December 15, 2025
Physical activity patterns after diagnosis and survival of prognostic colorectal cancer subgroups
Karel C Smit, Jeroen W G Derksen, Anne-Sophie van Lanen, et al.
Journal of Clinical Epidemiology
|
March 25, 2026
Learning from every patient: the 'outpatient innovation clinic'
Maarten J Kamphuis, Irene C van der Schaaf, Roxanne Gal, et al.
Nature
|
May 31, 2019
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano, Alessandro Leal, Jillian Phallen, et al.
The Lancet. Oncology
|
October 24, 2018
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2018
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.
JAMA Surgery
|
May 19, 2021
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial
Koen P Rovers, Checca Bakkers, Simon W Nienhuijs, et al.
The British Journal of Surgery
|
January 9, 2026
Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study
Carmen Rubio-Alarcón, Andrew Georgiadis, Ingrid A Franken, et al.
Medicine and Science in Sports and Exercise
|
December 11, 2023
Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after Diagnosis
Karel C Smit, Jeroen W G Derksen, Rebecca K Stellato, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 193) with videos related to
Sort By:
Page
of 20
Genome Medicine
|
August 15, 2024
Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD
Jonathan E Knikman, Qinglian Zhai, Carin A T C Lunenburg, et al.
Endoscopy
|
February 7, 2024
Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers
Lisa van der Schee, Krijn J C Haasnoot, Sjoerd G Elias, et al.
JNCI Cancer Spectrum
|
December 15, 2025
Physical activity patterns after diagnosis and survival of prognostic colorectal cancer subgroups
Karel C Smit, Jeroen W G Derksen, Anne-Sophie van Lanen, et al.
Journal of Clinical Epidemiology
|
March 25, 2026
Learning from every patient: the 'outpatient innovation clinic'
Maarten J Kamphuis, Irene C van der Schaaf, Roxanne Gal, et al.
Nature
|
May 31, 2019
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano, Alessandro Leal, Jillian Phallen, et al.
The Lancet. Oncology
|
October 24, 2018
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2018
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.
JAMA Surgery
|
May 19, 2021
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial
Koen P Rovers, Checca Bakkers, Simon W Nienhuijs, et al.
The British Journal of Surgery
|
January 9, 2026
Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study
Carmen Rubio-Alarcón, Andrew Georgiadis, Ingrid A Franken, et al.
Medicine and Science in Sports and Exercise
|
December 11, 2023
Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after Diagnosis
Karel C Smit, Jeroen W G Derksen, Rebecca K Stellato, et al.
Page
of 20